Clinical Trial Update: Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys [Phase 2, Phase 3]

View source ↗

Summary

Arimidex (anastrozole) was studied in growth hormone-deficient boys with hypopituitarism in a multicenter Phase 2/Phase 3 trial. The sponsor is Nemours Children…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Hypopituitarism

Drugs mentioned

• ARIMIDEX (anastrozole)

Snippet

Sponsor: Nemours Children's Clinic | Conditions: Hypopituitarism | Phase 2, Phase 3 | Status: COMPLETED